
T2D.com Review
Best for: diabetic GLP-1 access
T2D.com offers a complete service for compounded semaglutide and tirzepatide that includes the prescriber, medication, and home delivery in one integrated solution. A subsidiary of Vertical Insight Corp, the program is built specifically for individuals managing type 2 diabetes and pre-diabetes.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
T2D.com is a solid telehealth option with balanced features and pricing.
T2D.com at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $999/mo
- What's included
- Medication · Consult · Shipping
- Availability
- 1 states
- FDA status
- No FDA warning letter on record
How we scored T2D.com
Each dimension is scored algorithmically from T2D.com’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
4.8/10At $999/mo, T2D.com runs about 488% above the $170 median for GLP-1 providers.
Effectiveness25%
7.4/10T2D.com offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.7/10Online intake and platform experience — consult included in the price; 7 platform features disclosed.
Trust & Safety15%
6.6/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-03).
Accessibility10%
4.9/10T2D.com operates in a limited 1-state footprint — check availability first.
Support10%
5.2/10T2D.com provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this T2D.com review
Last checked 2026-06-03- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in 1 state
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications T2D.com offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Ready to get started?
Plans and promotions change often — check T2D.com's current pricing and active discounts before you decide.
What we like
- Built specifically for type 2 diabetic and pre-diabetic patients
- Integrated service — prescriber, pharmacy, and delivery handled in one flow
- Offers both compounded semaglutide and compounded tirzepatide
- Temperature-controlled home delivery via UPS or FedEx
- Ongoing prescriber monitoring and support included
Watch-outs
- No pricing published on the public website — must register to see costs
- No states list published on the site
- Newer brand with limited independent reviews
- Compounded only — no brand-name Ozempic, Wegovy, or Mounjaro
T2D.com: a GLP-1 program built around the diabetes diagnosis, not the diet
Most compounded GLP-1 services lead with weight loss and treat diabetes as an afterthought. T2D.com flips that. It is a subsidiary of Vertical Insight Corp built specifically for people managing type 2 diabetes and pre-diabetes, and it bundles three things that patients usually have to assemble themselves — the prescriber, the medication, and home delivery — into a single service. If you have a confirmed type 2 or pre-diabetic diagnosis and you want one company to handle the whole chain rather than juggling a telehealth visit here and a pharmacy there, this provider is aimed squarely at you. If you are a general weight-loss shopper with no metabolic diagnosis, you are not its target and you will likely find a better fit elsewhere.
How the 'everything included' model actually works
T2D.com is explicit that your medication is part of the service, not a separate line item. In its own words, the drug is "included as part of the service… not a separate purchase," and the program runs "from prescription to delivery," with the treatment "delivered directly to your door." Practically, that means one enrollment covers the prescriber visit, the compounded medication, and shipping — you are paying for an outcome (getting on therapy and staying on it) rather than itemizing a consult fee, a pharmacy charge, and a delivery charge the way some competitors do.
The catch is transparency. T2D.com does not publish its pricing on the public site — you have to register before any cost is shown. We could not independently verify a standard monthly rate, so treat any figure you see quoted elsewhere with caution and confirm the real number inside your own account before you commit. A service that hides the price until after you hand over contact details is asking for more trust up front than one that posts it plainly, and that is worth factoring in.
What you can expect to pay attention to
- Pricing is register-gated, so budget for an unknown until you enroll and see your quoted rate
- The category median for compounded GLP-1 programs sits around $170 a month — use that as your sanity check when T2D.com finally shows you a number
- Because the medication is bundled, compare the all-in figure against rivals' all-in totals, not against a bare drug price
The medications: compounded semaglutide and tirzepatide, no brand option
T2D.com offers both semaglutide and tirzepatide — the two heavyweight GLP-1 molecules, and notably it carries the tirzepatide option that many smaller programs skip. Both are compounded, not brand-name. That is the trade-off worth understanding: you will not get FDA-approved Ozempic, Wegovy, Mounjaro, or Zepbound here. Compounded versions are mixed by a pharmacy rather than manufactured by Novo Nordisk or Eli Lilly, which is how the price comes down, but it also means the product sits outside the FDA's brand-approval pathway. For a diabetic patient who has weighed that with their prescriber, it is a legitimate access route; for someone who specifically wants the branded pen, this is not the place.
Fulfillment is a genuine strength. Medication ships temperature-controlled via UPS or FedEx — important for GLP-1s, which are sensitive to heat — and the program includes ongoing prescriber monitoring rather than a one-and-done prescription.
What genuinely sets it apart
The real differentiator is focus. This is not a general weight-loss storefront that happens to accept diabetic patients; the entire program — intake, prescriber, and support — is structured around type 2 diabetes and pre-diabetes. Its badges spell out the model plainly: Prescriber Included, Medication Included, Home Delivery. For a population that often falls through the cracks between a diabetes clinic and a cash-pay weight-loss site, having one integrated service that speaks to the diagnosis directly is a meaningful reason to look here first.
Who should choose it — and who should skip it
- Choose it if: you have a type 2 or pre-diabetes diagnosis, you want prescriber, medication, and delivery handled in one flow, and you are comfortable with compounded therapy
- Choose it if: you want access to compounded tirzepatide, not just semaglutide
- Skip it if: you want a price you can see before sharing your details — the register-gate is a real friction point
- Skip it if: you need brand-name Ozempic, Wegovy, or Mounjaro
- Skip it if: you want to confirm your state is covered before signing up — T2D.com does not publish a states list
Trust, safety, and what we could confirm
On the safety ledger, there is good news and a few unknowns. The good: there are no FDA warning letters on file for this provider, the prescriber is included in the service, and shipping is temperature-controlled — all signs of a program that takes the clinical basics seriously. The unknowns: T2D.com discloses no compounding-pharmacy partner publicly, so we cannot point you to a named, accredited facility the way we can with some competitors, and it does not list which states it operates in. It is also a newer brand with limited independent reviews. None of that is disqualifying, but it does mean you are relying more on the company's own representations and less on outside verification. You can see how we weigh these factors in our scoring methodology.
Bottom line
T2D.com is a focused, fully bundled GLP-1 service for diabetic and pre-diabetic patients who value having one company manage the prescriber, the compounded medication, and the cold-chain delivery end to end. The integrated model and the inclusion of both compounded semaglutide and tirzepatide are real advantages. The friction is transparency: you cannot see the price or confirm your state without registering, the pharmacy partner is undisclosed, and the track record is still thin. If you fit the diagnosis and you are willing to register to pull back the curtain on cost and coverage, it is worth a serious look — just confirm your actual monthly rate and state eligibility in writing before you commit.
Shopping around? Brightmeds ($325/month) and bmiMD ($99/month) are the nearest alternatives to T2D.com in our rankings.
Ready to start with T2D.com?
Starting at $999/month. See current pricing and start your free consultation.
T2D.com might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Alternatives to T2D.com
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this T2D.com review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with T2D.com?
Starting at $999/month. See current pricing and start your free consultation.